Agilon Health Financials
AGL Stock | USD 3.36 0.27 7.44% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Current Ratio | 1.55 | 1.2654 |
|
|
Investors should never underestimate Agilon Health's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Agilon Health's cash flow, debt, and profitability to make informed and accurate decisions about investing in agilon health.
Cash And Equivalents |
|
Agilon | Select Account or Indicator |
Understanding current and past Agilon Health Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Agilon Health's financial statements are interrelated, with each one affecting the others. For example, an increase in Agilon Health's assets may result in an increase in income on the income statement.
Agilon Health Stock Summary
Agilon Health competes with Ensign, Universal Health, Addus HomeCare, Encompass Health, and Surgery Partners. agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas. Agilon Health operates under Medical Care Facilities classification in the United States and is traded on New York Stock Exchange. It employs 646 people.Specialization | Health Care, Health Care Equipment & Services |
Instrument | USA Stock View All |
Exchange | New York Stock Exchange |
ISIN | US00857U1079 |
CUSIP | 00857U107 |
Location | California; U.S.A |
Business Address | 6210 East Highway |
Sector | Health Care Providers & Services |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.agilonhealth.com |
Phone | 562 256 3800 |
Currency | USD - US Dollar |
Agilon Health Key Financial Ratios
Return On Equity | -0.44 | ||||
Profit Margin | (0.04) % | ||||
Operating Margin | (0.07) % | ||||
Price To Sales | 0.23 X | ||||
Revenue | 6.06 B |
Agilon Health Key Balance Sheet Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Total Assets | 446.4M | 1.6B | 1.7B | 1.7B | 1.7B | 1.4B | |
Other Current Liab | 7.1M | 242.3M | 356.1M | 968.1M | 1.1B | 1.2B | |
Net Debt | (33.6M) | (991.6M) | (453.6M) | (55.3M) | (49.7M) | (52.2M) | |
Retained Earnings | (551.2M) | (957.7M) | (1.1B) | (1.3B) | (1.6B) | (1.7B) | |
Accounts Payable | 256.7M | 109.6M | 174.0M | 968.1M | 1.2B | 1.2B | |
Cash | 106.8M | 1.0B | 497.1M | 107.6M | 188.2M | 275.1M | |
Other Assets | 34.1M | 225.9M | 86.5M | 1.0 | 1.15 | 1.09 | |
Long Term Debt | 64.7M | 43.4M | 38.5M | 32.3M | 34.9M | 37.5M | |
Net Receivables | 144.6M | 293.4M | 492.4M | 942.5M | 1.0B | 546.9M | |
Other Current Assets | 42.8M | 33.7M | 81.7M | 49.3M | 35.1M | 46.9M | |
Total Liab | 731.1M | 494.7M | 656.9M | 1.1B | 1.3B | 891.1M | |
Net Invested Capital | (217.0M) | 1.1B | 1.1B | 700.4M | 505.9M | 559.6M | |
Total Current Assets | 294.2M | 1.4B | 1.5B | 1.5B | 1.5B | 1.2B | |
Capital Stock | 2.5M | 4.0M | 4.1M | 4.1M | 4.1M | 3.9M | |
Net Working Capital | 27.4M | 1.0B | 916.2M | 502.9M | 305.8M | 514.9M | |
Intangible Assets | 60.5M | 55.4M | 67.7M | 63.8M | 72.8M | 71.7M |
Agilon Health Key Income Statement Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Tax Provision | 865K | 886K | 1.6M | 1.1M | 1.5M | 1.0M | |
Net Interest Income | (8.1M) | (6.1M) | (4.5M) | (6.5M) | (6.2M) | (6.5M) | |
Interest Expense | 8.1M | 6.1M | 4.5M | 6.7M | 6.2M | 5.4M | |
Total Revenue | 1.2B | 1.8B | 2.7B | 4.3B | 6.1B | 3.1B | |
Gross Profit | 94.2M | 76.4M | 112.3M | 69.7M | 4.8M | 4.6M | |
Operating Income | (56.7M) | (394.0M) | (110.2M) | (232.1M) | (288.5M) | (303.0M) | |
Ebit | (54.2M) | (398.5M) | (86.2M) | (187.8M) | (169.0M) | (177.5M) | |
Ebitda | (40.1M) | (383.8M) | (72.4M) | (167.6M) | (150.9M) | (158.4M) | |
Cost Of Revenue | 1.1B | 1.8B | 2.6B | 4.2B | 6.1B | 3.0B | |
Income Before Tax | (62.3M) | (404.6M) | (105.7M) | (194.5M) | (248.8M) | (261.3M) | |
Net Income | (63.2M) | (405.5M) | (106.9M) | (262.6M) | (260.2M) | (273.2M) | |
Income Tax Expense | 865K | 886K | 1.2M | 791K | 909.7K | 766.7K | |
Minority Interest | 73K | (300K) | (311K) | 239K | (50K) | (52.5K) |
Agilon Health Key Cash Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Investments | 22.1M | (75.7M) | (412.2M) | (49.8M) | 139.9M | 146.9M | |
Change In Cash | (6.5M) | 915.7M | (547.1M) | (393.4M) | 79.5M | 83.5M | |
Free Cash Flow | (55.6M) | (161.6M) | (163.5M) | (187.0M) | (99.1M) | (104.0M) | |
Depreciation | 14.1M | 14.7M | 13.8M | 20.2M | 24.5M | 17.1M | |
Other Non Cash Items | (17.6M) | 9.8M | (7.2M) | 27.2M | 887K | 842.7K | |
Capital Expenditures | 2.4M | 13.4M | 32.7M | 30.8M | 41.3M | 22.8M | |
Net Income | (60.1M) | (406.8M) | (106.9M) | (262.8M) | (260.2M) | (273.2M) | |
End Period Cash Flow | 139.1M | 1.1B | 507.7M | 114.3M | 193.9M | 287.4M |
Agilon Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Agilon Health's current stock value. Our valuation model uses many indicators to compare Agilon Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Agilon Health competition to find correlations between indicators driving Agilon Health's intrinsic value. More Info.agilon health is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Agilon Health's Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Agilon Health by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.agilon health Systematic Risk
Agilon Health's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Agilon Health volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on agilon health correlated with the market. If Beta is less than 0 Agilon Health generally moves in the opposite direction as compared to the market. If Agilon Health Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one agilon health is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Agilon Health is generally in the same direction as the market. If Beta > 1 Agilon Health moves generally in the same direction as, but more than the movement of the benchmark.
Agilon Health Thematic Clasifications
agilon health is part of Healthcare investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Healthcare industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Healthcare industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
Healthcare | View |
Today, most investors in Agilon Health Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Agilon Health's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Agilon Health growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Agilon Health February 27, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Agilon Health help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of agilon health. We use our internally-developed statistical techniques to arrive at the intrinsic value of agilon health based on widely used predictive technical indicators. In general, we focus on analyzing Agilon Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Agilon Health's daily price indicators and compare them against related drivers.
Downside Deviation | 4.73 | |||
Information Ratio | 0.2255 | |||
Maximum Drawdown | 28.87 | |||
Value At Risk | (7.39) | |||
Potential Upside | 10.96 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in agilon health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For more information on how to buy Agilon Stock please use our How to buy in Agilon Stock guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agilon Health. If investors know Agilon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agilon Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 11.951 | Earnings Share (0.70) | Revenue Per Share | Quarterly Revenue Growth 0.442 | Return On Assets |
The market value of agilon health is measured differently than its book value, which is the value of Agilon that is recorded on the company's balance sheet. Investors also form their own opinion of Agilon Health's value that differs from its market value or its book value, called intrinsic value, which is Agilon Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agilon Health's market value can be influenced by many factors that don't directly affect Agilon Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agilon Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Agilon Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agilon Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.